These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1464423)

  • 1. From antilymphocyte serum to therapeutic monoclonal antibodies: first experiences with a chimeric CD4 antibody in the treatment of autoimmune disease.
    Riethmüller G; Rieber EP; Kiefersauer S; Prinz J; van der Lubbe P; Meiser B; Breedveld F; Eisenburg J; Krüger K; Deusch K
    Immunol Rev; 1992 Oct; 129():81-104. PubMed ID: 1464423
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-CD4 monoclonal antibodies in therapy: creation of nonclassical tolerance in the adult.
    Shizuru JA; Alters SE; Fathman CG
    Immunol Rev; 1992 Oct; 129():105-30. PubMed ID: 1361179
    [No Abstract]   [Full Text] [Related]  

  • 3. Human-murine chimeric CD4 monoclonal antibodies. A modern panacea for autoimmune disease?
    Riethmüller G; Deusch K; Sanders ME; Dalesandro MR; Kiefersauer S; Reiter C; Rieber EP
    Immunol Ser; 1993; 59():261-9. PubMed ID: 8461391
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunotherapy of autoimmune disease with anti-T cell antibodies.
    Sriram S
    Concepts Immunopathol; 1989; 7():162-72. PubMed ID: 2676177
    [No Abstract]   [Full Text] [Related]  

  • 5. A new chimeric monoclonal CD4 antibody for prevention of rejection after heart transplantation.
    Meiser BM; Reiter C; Ebel M; Uberfuhr P; Wenke K; Reichenspurner H; Rieber E; Riethmüller G; Reichart B
    Transplant Proc; 1992 Oct; 24(5):1734. PubMed ID: 1412816
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic strategies using monoclonal antibodies in autoimmune disease.
    Pankewycz O; Strom TB; Kelley VE
    Curr Opin Immunol; 1989 Apr; 1(4):757-63. PubMed ID: 2508704
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum.
    Maki T; Ichikawa T; Blanco R; Porter J
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3434-8. PubMed ID: 1565635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological treatment of autoimmune diseases.
    Kalden JR; Breedveld FC; Burkhardt H; Burmester GR
    Adv Immunol; 1998; 68():333-418. PubMed ID: 9505094
    [No Abstract]   [Full Text] [Related]  

  • 9. Chimeric CD4 monoclonal antibody cM-T412 as a therapeutic approach to rheumatoid arthritis.
    van der Lubbe PA; Reiter C; Breedveld FC; Krüger K; Schattenkirchner M; Sanders ME; Riethmüller G
    Arthritis Rheum; 1993 Oct; 36(10):1375-9. PubMed ID: 8216397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric monoclonal CD4 antibody--a novel immunosuppressant for clinical heart transplantation.
    Meiser BM; Reiter C; Reichenspurner H; Uberfuhr P; Kreuzer E; Rieber EP; Riethmüller G; Reichart B
    Transplantation; 1994 Aug; 58(4):419-23. PubMed ID: 7915442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From treatment of experimental allergic encephalomyelitis to clinical trials in multiple sclerosis.
    Steinman L; Lindsey JW; Alters S; Hodgkinson S
    Immunol Ser; 1993; 59():253-60. PubMed ID: 8461390
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-CD4 monoclonal antibodies in rheumatoid arthritis.
    Choy EH; Kingsley GH; Panayi GS
    Springer Semin Immunopathol; 1998; 20(1-2):261-73. PubMed ID: 9836381
    [No Abstract]   [Full Text] [Related]  

  • 13. The pharmacokinetics and human anti-mouse antibody response in rheumatoid arthritis patients treated with a chimeric anti-CD4 monoclonal antibody.
    Choy EH; Schantz A; Pitzalis C; Kingsley GH; Panayi GS
    Br J Rheumatol; 1998 Jul; 37(7):801-2. PubMed ID: 9714366
    [No Abstract]   [Full Text] [Related]  

  • 14. Antilymphocyte globulins in kidney transplantation.
    Kreis H
    Kidney Int Suppl; 1992 Oct; 38():S188-92. PubMed ID: 1405373
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunotherapy of autoimmune disease with T cell subset specific antibodies.
    Sriram S; Ranges GE
    Concepts Immunopathol; 1987; 4():275-86. PubMed ID: 3297338
    [No Abstract]   [Full Text] [Related]  

  • 16. [Application of chimeric and humanized antibodies to autoimmune diseases therapy].
    Noguchi H
    Nihon Rinsho; 1997 Jun; 55(6):1549-56. PubMed ID: 9200947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-proliferative effects induced by anti-CD4 human/murine chimeric antibody and murine anti-CD4 monoclonal antibody.
    Shen G; Zhu H; Wang X; Zhang Y; Zhu Z; Wang S
    J Tongji Med Univ; 1999; 19(1):6-9. PubMed ID: 12840865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of murine lupus with monoclonal anti-T cell antibody.
    Wofsy D; Ledbetter JA; Hendler PL; Seaman WE
    J Immunol; 1985 Feb; 134(2):852-7. PubMed ID: 3871218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of rheumatoid arthritis with a chimeric CD4 monoclonal antibody (cM-T412): immunopharmacological aspects and mechanisms of action.
    van der Lubbe PA; Reiter C; Miltenburg AM; Krüger K; de Ruyter AN; Rieber EP; Bijl JA; Riethmüller G; Breedveld FC
    Scand J Immunol; 1994 Mar; 39(3):286-94. PubMed ID: 8128188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New therapeutic approaches in autoimmune rheumatic diseases, with special emphasis on rheumatoid arthritis.
    Kalden JR; Manger B
    Br J Rheumatol; 1995 Mar; 34(3):193-6. PubMed ID: 7728390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.